All stock reports

BHEL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-31T23:40:22.167801+00:00

Metrics

latest_annual_period
2026-03-31
revenue
337821800000.0
net_income
16002600000.0
operating_cash_flow
58157000000.0
free_cash_flow
52266600000.0
total_assets
761856100000.0
total_liabilities
500390100000.0
total_equity
261466000000.0
cash
118666200000.0
total_debt
81869500000.0
revenue_growth
0.23494681261348394
earnings_growth
1.9973028657051883
net_margin
0.04736994474601698
roe
0.061203368698033396
debt_to_equity
0.31311719305760594
cash_conversion
3.6342219389349233
free_cash_flow_margin
0.15471648070077182
trailing_pe
57.154
forward_pe
51.2821
peg_ratio
Not supplied
price_to_book
5.3962
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-e4a536e42fcd294ccd96988df402d7d16a3a1b806608db5806f4730c8ea0be24
Policy
stock-decisions-v1
Evidence bundle hash
42ae93a44dcc274ea9db9a8b1e43fb47b15dfeac142eb0dd99bbb29bdc0a0569
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 0db55e22acc198025d5ff376f67f587d12b9759c0f4ee1dfc696f899c89afce6
  • daily-price: 7f6a9abcb836f31385335ca62f66c365485f45f13ca065210beed19229798cf0
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was 1.36%. The trailing 20-session price return was -1.52%. The trailing 60-session price return was 11.43%. The trailing 250-session price return was 82.83%. Average cached traded value over twenty sessions was INR 2,805,051,618.

Risks

The closing price was -4.89% below its highest close in the available trailing year. The cached financial metric net margin is 0.04736994474601698. The cached financial metric roe is 0.061203368698033396. The cached financial metric debt to equity is 0.31311719305760594. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.23494681261348394. The cached financial metric cash conversion is 3.6342219389349233. The cached financial metric free cash flow margin is 0.15471648070077182.

Cached observations and evidence limits